Ignite Creation Date:
2025-12-24 @ 4:36 PM
Ignite Modification Date:
2026-02-09 @ 3:21 PM
Study NCT ID:
NCT00378066
Status:
COMPLETED
Last Update Posted:
2013-01-23
First Post:
2006-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer
Sponsor:
Asan Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Colorectal Cancer | View |
Keywords: